Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Short Cervix or Preterm Delivery
and you are
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

The purpose of the study is to determine whether the Arabin pessary is a useful intervention of preterm birth at less than 37 weeks in women with a singleton gestation and a short cervix.

Provided treatments

  • Device: Pessary
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02901626. The sponsor of the trial is The George Washington University Biostatistics Center and it is looking for 850 volunteers for the current phase.
Official trial title:
A Randomized Trial of Pessary in Singleton Pregnancies With a Short Cervix